LIVN
HealthcareLivaNova PLC
Live · NASDAQ · May 9, Close
What's Moving LIVN Today?
No stock-specific AI insight has been generated for LIVN yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
LIVN News
22 articles- LivaNova (LIVN) Q1 2025 Earnings TranscriptMotley Fool·May 7, 2026
- LivaNova PLC Q1 2026 Earnings Call SummaryMoby·May 6, 2026
- LivaNova Q1 Earnings Call HighlightsMarketbeat·May 6, 2026
- LivaNova (LIVN) Q2 2025 Earnings TranscriptMotley Fool·May 6, 2026
- LivaNova (LIVN) Q3 2025 Earnings TranscriptMotley Fool·May 6, 2026
- LivaNova (LIVN) Q1 2026 Earnings TranscriptMotley Fool·May 6, 2026
- LivaNova (LIVN) beats quarterly expectations but shares slip on cautious guidance reactionAdvfn·May 6, 2026
- LivaNova (LIVN) Q1 Earnings and Revenues Surpass EstimatesYahoo Finance·May 6, 2026
- Global Perfusion Systems Market to Register Incremental Growth at a CAGR of ~5% by 2034 | DelveInsightGlobeNewswire Inc.·Apr 23, 2026
- Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep ApneaYahoo Finance·Apr 20, 2026
- AxoGen (AXGN) Surges 7.5%: Is This an Indication of Further Gains?Yahoo Finance·Apr 17, 2026
- Drug Resistant Epilepsy Market Insights, Epidemiology, and Forecasts, 2022-2026 & 2026-2036Yahoo Finance·Apr 13, 2026
- MedTech's Edge: How AI and Remote Diagnostics Drive Scalable ValueBenzinga·Mar 27, 2026
- Should FDA Approval of aura6000 Sleep Apnea Therapy Require Action From LivaNova (LIVN) Investors?Yahoo Finance·Mar 26, 2026
- LivaNova (LIVN) Announces FDA Approval of aura6000 System for Obstructive Sleep ApneaYahoo Finance·Mar 25, 2026
- LivaNova Expands OSA Care With FDA-Approved aura6000 SystemYahoo Finance·Mar 25, 2026
- LivaNova to Announce First-Quarter 2026 ResultsYahoo Finance·Mar 25, 2026
- LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep ApneaYahoo Finance·Mar 19, 2026
- Strength Seen in Tandem Diabetes Care (TNDM): Can Its 9.1% Jump Turn into More Strength?Yahoo Finance·Mar 18, 2026
- Down 7.2% in 4 Weeks, Here's Why You Should You Buy the Dip in LivaNova (LIVN)Yahoo Finance·Mar 13, 2026
- All You Need to Know About LivaNova (LIVN) Rating Upgrade to BuyYahoo Finance·Mar 5, 2026
- A Look At LivaNova (LIVN) Valuation After Earnings Show Growth Guidance And A Swing To Net LossYahoo Finance·Mar 3, 2026
All 22 articles loaded
Price Data
Fundamentals
Trading
About LivaNova PLC
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.